STATE STREET CORP - SUMMIT THERAPEUTICS INC ownership

SUMMIT THERAPEUTICS INC's ticker is SMMT and the CUSIP is 86627T108. A total of 50 filers reported holding SUMMIT THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
STATE STREET CORP ownership history of SUMMIT THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$4,238,484
-25.1%
2,266,569
+0.6%
0.00%
Q2 2023$5,657,477
+2543.4%
2,253,975
+1743.0%
0.00%
Q1 2023$214,025
-71.4%
122,300
-30.4%
0.00%
Q4 2022$747,150
-2.7%
175,800
-43.9%
0.00%
Q1 2022$768,000
-15.3%
313,401
-7.0%
0.00%
Q4 2021$907,000
-46.1%
337,114
+0.3%
0.00%
Q3 2021$1,684,000
-12.1%
336,198
+31.0%
0.00%
Q2 2021$1,915,000256,7000.00%
Other shareholders
SUMMIT THERAPEUTICS INC shareholders Q1 2022
NameSharesValueWeighting ↓
Polar Capital Holdings Plc 5,800,000$27,260,0000.16%
Inscription Capital, LLC 17,000$80,0000.03%
ExodusPoint Capital Management, LP 185,844$873,0000.01%
HoyleCohen, LLC 10,359$49,0000.01%
Virtu Financial LLC 10,835$51,0000.01%
Tower Research Capital LLC (TRC) 3,783$18,0000.00%
Renaissance Technologies 253,212$1,190,0000.00%
Baillie Gifford 372,261$1,749,0000.00%
CAPSTONE INVESTMENT ADVISORS, LLC 37,238$175,0000.00%
BREWIN DOLPHIN LTD 1,970$9,2590.00%
View complete list of SUMMIT THERAPEUTICS INC shareholders